Is AdreView safe for my child?

The safety and effectiveness of AdreView has been confirmed in clinical trial studies for children from one month to 16 years of age. Safety and effectiveness in children less than one month old has not been resolved. AdreView contains benzyl alcohol which has been associated with "Gasping Syndrome." This can be fatal for premature and low birth-weight infants.

Continue Learning about Diagnostic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.